Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERTAIN: Welchol + Niacin in Dyslipidemia/IFG
NCT01239004Phase 4Completed
- Sponsor
- Radiant Research
- Start
- Nov 2010
- Primary completion
- Aug 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colesevelam in dyslipidemia, impaired fasting glucose (IFG), sponsored by Radiant Research. Started Nov 2010; status: completed.
02
Drugs
colesevelam
03
Conditions
dyslipidemiaimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on NCT01239004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239004.